A population pharmacokinetic analysis for BIBF 1120, an angiokinase inhibitor, in patients with advanced non-small-cell lung cancer (NSCLC)

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 14528-14528 ◽  
Author(s):  
M. Freiwald ◽  
K. Liesenfeld ◽  
R. Bruno ◽  
L. Hodge ◽  
P. Stopfer ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Population Pharmacokinetic Analysis ◽  
Small Cell ◽  
Pharmacokinetic Analysis ◽  
Population Pharmacokinetic ◽  
Small Cell Lung ◽  
Bibf 1120

scholarly journals BIBF 1120/nintedanib: a new triple angiokinase inhibitor-directed therapy in patients with non-small cell lung cancer

2013 ◽  
Vol 22 (8) ◽  
pp. 1081-1088 ◽  
Author(s):  
Christian Rolfo ◽  
Luis E Raez ◽  
Giuseppe Bronte ◽  
Edgardo S Santos ◽  
Kostantinos Papadimitriou ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Bibf 1120
Sign in / Sign up

Export Citation Format

Share Document